Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826) has released an update.
Shanghai Haohai Biological Technology Co., Ltd. has revised the price cap for its A Share repurchase plan from RMB130.00 to RMB92.48 following the distribution of a final dividend and the issuance of capitalization shares. This adjustment comes after shareholder approval of the repurchase plan, which aims to buy back shares with funds between RMB100 million and RMB200 million within 12 months. Shareholders are reminded to be cautious when trading the company’s shares during this period.
For further insights into HK:6826 stock, check out TipRanks’ Stock Analysis page.
